Hyam Levitsky

Hyam Levitsky

Chief Tech/Sci/R&D Officer bij CENTURY THERAPEUTICS, INC.

Vermogen: 2 M $ op 31-03-2024

66 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Hyam I.
Levitsky
currently works at Replimune Group, Inc., as Independent Director from 2018, Prokarium Ltd., as Director from 2020, Cancer Research Institute, as Member-Cancer Immunotherapy Consortium, American Association for Cancer Research, as Member, American Society of Hematology, as Member, and Century Therapeutics, Inc., as President-Research & Development from 2023.
Dr. Levitsky also formerly worked at Agenus, Inc., as Director from 2006 to 2011, The Johns Hopkins University, as Scientific Director from 2005 to 2011, Carisma Therapeutics, Inc., as Director, Roche Holding AG, as Head-Cancer Immunology Experimental Medicine from 2011 to 2015, F.
Hoffmann-La Roche Ltd., as Head-Cancer Immunotherapy Experimental Medicine from 2011 to 2015, Roche Pharmaceuticals, Inc., as Head-Cancer Immunology, American Society for Clinical Investigation, as Member, The Sidney Kimmel Comprehensive Cancer Center, as Professor from 2002 to 2011, The Johns Hopkins University School of Medicine, as Professor, Juno Therapeutics, Inc., as Chief Scientific Officer & Executive VP from 2015 to 2018, Century Therapeutics, Inc., as President-Research & Development from 2019 to 2023, and Century Therapeutics, Inc., as President-Research & Development.
Dr. Levitsky received his doctorate degree in 1984 from The Johns Hopkins University School of Medicine and undergraduate degree in 1980 from School of Engineering & Applied Science.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
07-03-2024 560 544 ( 0.70% ) 2 M $ 31-03-2024
01-04-2024 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Hyam Levitsky

BedrijvenFunctieBegin
REPLIMUNE GROUP, INC. Director/Board Member 01-05-2018
CENTURY THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 11-04-2023
Director/Board Member 01-10-2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Alle actieve functies van Hyam Levitsky

Eerdere bekende functies van Hyam Levitsky

BedrijvenFunctieEinde
CENTURY THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01-01-2023
JUNO THERAPEUTICS INC Chief Tech/Sci/R&D Officer 01-04-2018
ROCHE HOLDING AG Corporate Officer/Principal 01-02-2015
░░ ░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Ervaring van Hyam Levitsky in detail bekijken

Opleiding van Hyam Levitsky

The Johns Hopkins University School of Medicine Doctorate Degree
School of Engineering & Applied Science Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Hyam Levitsky in detail bekijken

Connecties

100 +

Eerstegraads connecties

18

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven5
ROCHE HOLDING AG

Health Technology

AGENUS INC.

Health Technology

REPLIMUNE GROUP, INC.

Health Technology

CENTURY THERAPEUTICS, INC.

Health Technology

CARISMA THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit10

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Hyam Levitsky